Sign in
4

Changes in Ownership

INTERPACE BIOSCIENCES, INC. Filed Acc 0001493152-17-010977

Options or other derivatives

  • Chief Financial Officer acquired 40,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Early James Chief Financial Officer 2017-09-26 Grant or award · Stock Option (right to buy) +40,000 40,000 D
Loading xslF345X03/form4.xml…